ResMed

ResMed develops and manufactures cloud-connected medical devices and software solutions primarily for the diagnosis, treatment, and management of sleep-disordered breathing and other respiratory conditions. The company's core offerings include continuous positive airway pressure (CPAP) machines, masks, and accessories for sleep apnea, alongside ventilators for chronic obstructive pulmonary disease (COPD) and other respiratory ailments. These integrated systems aim to enhance patient care and improve health outcomes through data-driven insights.

The company was established in 1989 by Dr. Peter Farrell. His foundational insight stemmed from the pioneering work on CPAP therapy for obstructive sleep apnea conducted at the University of Sydney. Dr. Farrell recognized the significant unmet need for effective treatments and sought to commercialize and widely distribute this life-changing technology to a global patient population.

ResMed’s products serve individuals suffering from sleep apnea, COPD, and various chronic respiratory diseases, as well as the healthcare professionals who care for them. The company is committed to transforming chronic disease management through its innovative digital health solutions. Its long-term vision centers on empowering individuals to live healthier, higher-quality lives by expanding access to and improving the efficacy of its respiratory care technologies.